SYNDAX PHARMACEUTICALS INC

Ticker: SNDX CUSIP: 87164F105 Class: Common Stock

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 126,145 Value ($000) $1,181 Avg Close $11.01 Range $8.58 - $14.24
Q1 2025
Shares 1,817,009 Value ($000) $22,322 Avg Close $14.10 Range $12.06 - $16.95
Q4 2024
Shares 69,586 Value ($000) $920 Avg Close $17.11 Range $12.40 - $22.50
Q3 2024
Shares 367,177 Value ($000) $7,068 Avg Close $20.66 Range $17.34 - $25.07
Q4 2023
Shares 165,018 Value ($000) $3,566 Avg Close $15.37 Range $11.21 - $21.84
Q3 2023
Shares 148,524 Value ($000) $2,157 Avg Close $18.92 Range $12.85 - $23.55
Q2 2023
Shares 99,674 Value ($000) $2,086 Avg Close $20.82 Range $19.27 - $23.14
Q1 2023
Shares 19,102 Value ($000) $403 Avg Close $24.88 Range $20.01 - $29.86
Q2 2018
Shares 10,413 Value ($000) $73 Avg Close $9.81 Range $6.61 - $15.20
Q1 2018
Shares 14,813 Value ($000) $211 Avg Close $10.61 Range $8.44 - $14.96
Q4 2017
Shares 48,806 Value ($000) $428 Avg Close $9.90 Range $7.70 - $13.48